Is Insulin the Only Treatment for Obese NIDDM Patients Poorly Controlled By Oral Hypoglycemic Agents?b
Open Access
- 1 June 1998
- journal article
- letter
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 83 (6) , 2215
- https://doi.org/10.1210/jc.83.6.2215
Abstract
In their paper on 1-yr insulin treatment of obese and nonobese NIDDM patients poorly controlled by oral hypoglycemic agents, Yki-Jarvinen et al. (1) have shownThis publication has 8 references indexed in Scilit:
- Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart DiseaseThe American Journal of Medicine, 1997
- The Feasibility of Intensive Insulin Management in Non-Insulin-dependent Diabetes Mellitus: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDMAnnals of Internal Medicine, 1996
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- The Efficacy of Acarbose in the Treatment of Patients with Non–Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical TrialAnnals of Internal Medicine, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS IN NON-OBESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES IS RELATED TO REDUCED INSULIN RELEASE1989
- EVALUATION OF A STRUCTURED TREATMENT AND TEACHING PROGRAMME ON NON-INSULIN-DEPENDENT DIABETESThe Lancet, 1988